Dehydronorketamine · Lablypedia

In a nutshell

Dehydronorketamine (DHNK), or 5,6-dehydronorketamine, is a minor metabolite of ketamine which is formed by dehydrogenation of its metabolite norketamine. Though originally considered to be inactive, DHNK has been found to act as a potent and selective negative allosteric modulator of the α₇-nicotinic acetylcholine receptor (IC₅₀ = 55 nM). For this reason, similarly to hydroxynorketamine (HNK), it has been hypothesized that DHNK may have the capacity to produce rapid antidepressant effects. However, unlike ketamine, norketamine, and HNK, DHNK has been found to be inactive in the forced swim test (FST) in mice at doses up to 50 mg/kg. DHNK is inactive at the α₃β₄-nicotinic acetylcholine receptor (IC₅₀ > 100 μM) and is only very weakly active at the NMDA receptor (K_i = 38.95 μM for (S)-(+)-DHNK). It can be detected 7–10 days after a modest dose of ketamine, and because of this, is useful in drug detection assays.

Related on Lably

Through Metabolite

Lab · Class 11Biomolecules — Animated Chapter Film

BiomoleculesClass 11 · Biology

More in Health

Food and Drug AdministrationFederal agency of the United States Department of Health and Human Services Centers for Disease Control and PreventionUnited States government public health agency NauseaMedical symptom or condition SeizurePeriod of symptoms due to excessive or synchronous neuronal brain activity VomitingExpulsion of stomach contents via the mouth or nose Intravenous therapyMedication administered into a vein